SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-Jan-23 5:28 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 27-Jan-23 | Disposition (other) Duplicate | 1,033,000 | -- | -- | (4%) 24.76M to 23.73M | |
09-Aug-22 5:19 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 08-Aug-22 | Purchase Duplicate | 8,000,000 | $1.55 | $12,400,000.00 | 48% 16.76M to 24.76M | |
23-Nov-20 5:13 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 20-Nov-20 | Disposition (other) Duplicate | 4,936,930 | -- | -- | (23%) 21.7M to 16.76M | |
15-Jan-20 4:13 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 13-Jan-20 | Market Purchase Duplicate | 1,250,000 | $5.00 | $6,250,000.00 | 6% 20.45M to 21.7M | |
26-Nov-19 5:36 PM View: | Optinose, Inc. (OPTN) | 25-Nov-19 | Market Sale | 1,250,000 | $9.16 | $11,456,200.00 | (8%) 15.52M to 14.27M | 49% |
13-Jun-18 4:50 PM View: | Optinose, Inc. (OPTN) | 11-Jun-18 | Market Sale | 2,875,000 | $20.92 | $60,130,600.00 | (16%) 18.4M to 15.52M | 78% |
19-Oct-17 5:38 PM View: | Optinose, Inc. (OPTN) | 17-Oct-17 | Grant | 1,250,000 | $16.00 | $20,000,000.00 | 883% 141.61K to 1.39M | |
19-Oct-17 5:38 PM View: | Optinose, Inc. (OPTN) | 17-Oct-17 | Conversion | 17,006,400 | -- | -- | 1222% 1.39M to 18.4M | |
21-Mar-17 5:00 PM View: | Lantheus Holdings, Inc. (LNTH) | 17-Mar-17 | Market Sale Duplicate | 3,000,000 | $12.20 | $36,600,000.00 | (20%) 15.29M to 12.29M | (21%) |
23-Nov-16 4:33 PM View: | Lantheus Holdings, Inc. (LNTH) | 21-Nov-16 | Market Sale Duplicate | 2,500,000 | $9.00 | $22,500,000.00 | (14%) 17.79M to 15.29M | (56%) |